Skip to main content

Deep learning-based spot weight generation for online adaptive IMPT: implementation and technical feasibility on a clinical delivery system

Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Q1)
Published
13 October 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Bo Pang, Hong Quan, Tian Li, Heng Li, Minglei Kang, Lian Zhang, et al.
PMID
42869249
DOI
10.1016/j.radonc.2026.111824

Why clinicians should know about it

  • Picked for Medical Physics (paper of the day, 17 October 2026): Deep learning spot‑weight generation for IMPT workflow

Abstract

PURPOSE: To investigate the feasibility of a deep learning-based method for generating intensity-modulated proton therapy (IMPT) spot weights to enable a faster, more automated workflow. METHODS: A 3D Attention U-Net with a masked mean absolute error loss generated spot weights from four input channels (optimized plan dose, reference dose, CT image, spot mask), using planned spot weights as labels, and trained and tested on prostate, brain, and lung cases. Robustness was evaluated on target dose metrics only. The workflow was validated in the Eclipse® treatment planning system and delivered on a ProBeam 360° system. RESULTS: For weights in the range 0-5, mean absolute errors were below 0.8 for the prostate and brain models (15.9% and 48.1% of all weights, respectively) and below 1.7 for the lung model (31.2%). Mean relative errors were below 10% for the prostate model (5-65, 83.7%), 20% for the brain model (5-65, 51.7%), and 40% for the lung model (5-110, 68.6%); the remaining weights lay above these ranges and accounted for <0.5% of all weights. Gamma passing rates within the body contours (2%, 2 mm, 10% dose threshold) were 99.73 ± 0.32%, 98.95 ± 0.86%, and 92.75 ± 3.52% for the prostate, brain, and lung models, respectively. All delivered plans met the clinical QA acceptance criteria. CONCLUSION: The proposed framework demonstrates the technical feasibility of generating IMPT spot weights with deep learning and implementing them on a clinical delivery system. Further improvement is needed for heterogeneous sites such as the lung.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.